Emcure Pharmaceuticals plans Rs 600 crore IPO

01 Jul 2013 Evaluate

Emcure Pharmaceuticals is planning to garner about Rs 600 crore through an initial public offering (IPO). In this regard, Blackstone backed Pune-based pharma company has filed its draft prospectus with SEBI to offer upto 29 per cent stake in the company.

DSP Merrill Lynch, IDFC Capital and Morgan Stanley India Company have been appointed as book running lead managers to the issue.

Emcure Pharmaceuticals develops, manufactures and markets a broad range of pharmaceutical products in major therapeutic areas including blood related, cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients products.

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×